After manufacturing issues, AstraZeneca hopes for FDA nod soon.
Decision wipes $24 billion from share price
Move sparks speculation that Amazon is making e-Health records product
This week’s news
GSK is left as sole bidder amid speculation that the sale is off.
Gene sequencing upstart Oxford Nanopore raises another $140m in its bid to enable the analysis of “any living thing, by anyone, anywhere.”
The chief executive of GlaxoSmithKline has welcomed the breakthrough in talks between the UK and EU27 countries on a transition or ‘implementation’ period.
Mundipharma’s third biosimilar tie-up with Celltrion
Vertex ‘astonished and dismayed’ by NHS rejection
Crackdown follows last year’s declaration of a ‘national emergency’
Up and coming immunotherapy company Autolus has published details of an ‘off switch’ safety features in its next generation CAR-Ts.